Rchr
J-GLOBAL ID:201601003376230891   Update date: Oct. 25, 2024

SHIRAI Katsuyuki

SHIRAI Katsuyuki
Affiliation and department:
Job title: Professor
Research field  (1): Tumor diagnostics and therapeutics
Research theme for competitive and other funds  (8):
  • 2020 - 2024 前立腺癌術後照射患者における免疫チェックポイント分子機構の予後への影響
  • 2017 - 2022 The effect of immune-checkpoint pathway on the prognosis in head and neck cancer treated with radiotherapy
  • 2016 - 2020 Basic and clinical research for advanced cancer heavy ion radiotherapy and individualized treatment
  • 2014 - 2017 The effect of HPV status on radiation sensitivity of photon and carbon-ion radiotherapy in head and neck squamous cell carcinoma
  • 2013 - 2016 An Attempt to Establish the Technology for Estimating Real Irradiated Dose of Particle Therapy in a Living Body
Show all
Papers (116):
  • Katsuyuki Shirai, Shuri Aoki, Masashi Endo, Yuta Takahashi, Yukiko Fukuda, Keiko Akahane, Atsushi Musha, Harutoshi Sato, Masaru Wakatsuki, Hitoshi Ishikawa, et al. Recent developments in the field of radiotherapy for the management of lung cancer. Japanese journal of radiology. 2024
  • Osamu Manabe, Hiroyuki Jinnouchi, Tadao Aikawa, Katsuyuki Shirai, Noriko Oyama-Manabe. Ischemia in the RV and LV, and rheumatoid myalgia incidentally found in a lung cancer patient treated with immune checkpoint inhibitors: A case report with FDG PET/CT imaging. European heart journal. Cardiovascular Imaging. 2023
  • Masashi Endo, Yukiko Fukuda, Kohei Okada, Kazunari Ogawa, Michiko Nakamura, Satoru Takahashi, Eri Murakami, Chiaki Shibayama, Masahiro Kawahara, Keiko Akahane, et al. Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation. In Vivo. 2023. 37. 5. 2320-2326
  • MASASHI ENDO, YUKIKO FUKUDA, KOHEI OKADA, KAZUNARI OGAWA, MICHIKO NAKAMURA, SATORU TAKAHASHI, ERI MURAKAMI, CHIAKI SHIBAYAMA, MASAHIRO KAWAHARA, KEIKO AKAHANE, et al. Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation. In Vivo. 2023. 37. 5. 2320-2326
  • Atsushi Musha, Nobuteru Kubo, Hidemasa Kawamura, Naoko Okano, Hiro Sato, Kohei Okada, Kento Tomizawa, Norichika Ota, Akiko Adachi, Masato Shino, et al. Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon-ion radiotherapy. Cancer reports (Hoboken, N.J.). 2023. 6. 7. e1825
more...
MISC (147):
more...
Work history (2):
  • Gunma University Research Center for Heavy Particle Beam Medicine
  • Gunma University
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page